BriaCell Therapeutics Corp.

NASDAQ : BCTXW

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Information

Website
https://briacell.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
Canada

Price

USD 0.28

Symbol

BCTXW

Type

Common Stock

Previous Close

 :

0.24

52 Week Range

 :

0.11 - 2.54

Volume

 :

26,451.00

Average Volume

 :

24,021.00

High

 :

0.28

Low

 :

0.17

Change

 :

0.04

Percent change (%)

 :

14.58

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...